AD

2-Methyl-2-propanyl methyl[(3R)-3-pyrrolidinyl]carbamate(CAS: 392338-15-7)

2-Methyl-2-propanyl methyl[(3R)-3-pyrrolidinyl]carbamate
CAS Number

Related Products

Other Suppliers for 2-Methyl-2-propanyl methyl[(3R)-3-pyrrolidinyl]carbamate

Basic Information

Molecular Formula
C10H20N2O2
Molecular Weight
200.28 g/mol
Physical State
Pale-yellow to Yellow-brown Liquid

Physical Properties

Boiling Point
268 ºC
Flash Point
116 ºC

Chemical Identifiers

SMILES
CC(C)(C)OC(=O)N(C)C1CCNC1
InChIKey
XYKYUXYNQDXZTD-MRVPVSSYSA-N

Database References

MDL Number
MFCD09263387

FAQ

2-Methyl-2-propanyl methyl[(3R)-3-pyrrolidinyl]carbamate is a colorless or white crystalline solid with a molecular weight of approximately 265.43 g/mol. It has a pKa of about 8.5 and a solubility of about 10 g/L in water. This compound is moderately reactive and susceptible to hydrolysis in acidic and basic conditions.
2-Methyl-2-propanyl methyl[(3R)-3-pyrrolidinyl]carbamate is typically synthesized by the reaction between 2-methyl-2-propanol and methyl (3R)-3-pyrrolidinyl carbamate in the presence of a catalytic amount of a strong base such as sodium hydride. The yield is approximately 85-90%, and the reaction is carried out at room temperature.
2-Methyl-2-proanyl methyl[(3R)-3-pyrrolidinyl]carbamate is used in the pharmaceutical and chemical industries for its potential as a bioisostere in drug design. It is also utilized in the development of sensors and as a building block in organic synthesis.
When handling 2-Methyl-2-proanyl methyl[(3R)-3-pyrrolidinyl]carbamate, wear appropriate personal protective equipment (PPE) such as gloves, safety goggles, and a lab coat. Store the compound in a cool, dry place away from direct sunlight. In case of a spill, clean up immediately using appropriate methods and consult the Safety Data Sheet (SDS) for detailed instructions.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

kevin@resuperpharmtech.com